Subscribe to Real-World Patient-Reported Outcomes After Initiation of Adjuvant Ribociclib Plus Endocrine Therapy in Early HR+/HER2− Breast Cancer: A Multicentre Prospective Observational Study in Croatia (PRO-QoL-Cro)